After years of pitched battles with an activist shareholder unhappy with his leadership, Dow Chemical's Darwin-born chief executive, Andrew Liveris, plans to retire by mid-2017.
Liveris told analysts he would step aside by the second half of next year. The news represents a victory for Daniel Loeb, the head of New York hedge fund Third Point. The fund has a 2 per cent stake in Dow and Loeb has been questioning Dow's leadership since 2014, amid slumping share prices.
